Veru, Inc. (VERU)
3.32
+0.32
(+10.67%)
USD |
NASDAQ |
Jun 09, 13:36
Veru EPS Diluted (Quarterly) : -0.1342 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Johnson & Johnson | 2.141 |
| Eli Lilly & Co. | 8.255 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.093M |
| Total Expenses (Quarterly) | 3.093M |
| Enterprise Value | 20.22M |
| Earnings Yield | -24.34% |
| Normalized Earnings Yield | -27.84 |